Cefditoren
| Title | Journal |
|---|---|
| Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | Chemical research in toxicology 20150518 |
| In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. | Diagnostic microbiology and infectious disease 20120601 |
| Serum sickness-like reaction in children due to cefditoren. | Pediatric dermatology 20120101 |
| Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains. | PloS one 20120101 |
| Cefditoren in upper and lower community-acquired respiratory tract infections. | Drug design, development and therapy 20110101 |
| Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study. | Diagnostic microbiology and infectious disease 20100701 |
| Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20100601 |
| Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren. | Journal of chemotherapy (Florence, Italy) 20100601 |
| In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections. | The Japanese journal of antibiotics 20100201 |
| Wegener's granulomatosis presented as recurrent breast abscess. | The breast journal 20100101 |
| Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model. | PloS one 20100101 |
| Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters. | Drug metabolism and pharmacokinetics 20100101 |
| In vitro activity of cefditoren versus other antibiotics against S. pneumoniae clinical strains isolated in Italy. | International journal of immunopathology and pharmacology 20100101 |
| [Cefditoren and community-acquired lower respiratory tract infections (corrected)]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20090901 |
| Cefditoren versus community-acquired respiratory pathogens: time-kill studies. | Journal of chemotherapy (Florence, Italy) 20090801 |
| PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro. | European journal of pharmacology 20090610 |
| Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach. | The Journal of antimicrobial chemotherapy 20090601 |
| Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations. | Diagnostic microbiology and infectious disease 20090601 |
| Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20090601 |
| New antimicrobial molecules and new antibiotic strategies. | Seminars in respiratory and critical care medicine 20090401 |
| In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. | Diagnostic microbiology and infectious disease 20081001 |
| Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy. | Journal of chemotherapy (Florence, Italy) 20081001 |
| Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States. | Diagnostic microbiology and infectious disease 20080601 |
| Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight Central, East and Baltic European countries in 2005-06: results of the Cefditoren Surveillance Study. | The Journal of antimicrobial chemotherapy 20080501 |
| Monte Carlo simulation describing the pharmacodynamic profile of cefditoren in plasma from healthy volunteers. | International journal of antimicrobial agents 20080401 |
| Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006). | Journal of chemotherapy (Florence, Italy) 20080401 |
| Efficacy of cefditoren in the treatment of upper respiratory tract infections: a pooled analysis of six clinical trials. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080301 |
| High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation. | PloS one 20080101 |
| In vitro activity of cefditoren against clinical isolates of Escherichia coli from a Korean hospital. | International journal of antimicrobial agents 20070901 |
| Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. | The Journal of antimicrobial chemotherapy 20070801 |
| Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin-resistant Streptococcus pneumoniae. | The Journal of antimicrobial chemotherapy 20070701 |
| Pharmacodynamics of simulated total versus free-drug serum concentrations of a low versus a high protein bound third-generation oral cephalosporin (Cefpodoxime versus cefditoren) against Streptococcus pneumoniae. | Journal of chemotherapy (Florence, Italy) 20070601 |
| In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents. | International journal of antimicrobial agents 20070401 |
| Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view? | The Journal of antimicrobial chemotherapy 20070401 |
| Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20070301 |
| Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones. | International journal of antimicrobial agents 20070201 |
| In vitro activities of oral cephem and telithromycin against clinical isolates of major respiratory pathogens in Japan. | Journal of Korean medical science 20070201 |
| [Influence of the displacement of protein binding by ibuprofen in the activity of a third-generation cephalosporin against Streptococcus pneumoniae]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20061201 |
| [Relationship between protein binding and antimicrobial activities of antibiotics against Streptococcus pneumoniae and Haemophilus influenzae]. | The Japanese journal of antibiotics 20061001 |
| In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries. | International journal of antimicrobial agents 20060701 |
| [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution]. | The Japanese journal of antibiotics 20060601 |
| [Clinical effect of ceftriaxone and cefditoren administration against oral and genital gonococcal infection]. | The Japanese journal of antibiotics 20060201 |
| Quantification of the cephalosporin antibiotic cefditoren in human plasma by high-performance liquid chromatography. | Arzneimittel-Forschung 20060101 |
| Beta-lactam antibiotics: newer formulations and newer agents. | Infectious disease clinics of North America 20040901 |
| Antimicrobial susceptibility of respiratory Haemophilus influenzae strains isolated from pediatric respiratory tract infections. | Pediatrics international : official journal of the Japan Pediatric Society 20040801 |
| Myeloperoxidase in nasal secretion as a cell-activation marker in acute sinusitis. | American journal of rhinology 20040101 |
| Simultaneous intravenous and intramiddle-ear dosing to determine cefditoren influx and efflux clearances in middle ear fluid in freely moving chinchillas. | Journal of pharmaceutical sciences 20031001 |
| [Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs]. | The Japanese journal of antibiotics 20030601 |
| In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary. | Acta microbiologica et immunologica Hungarica 20030101 |
| [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001]. | The Japanese journal of antibiotics 20021201 |
| Cefditoren, a new aminothiazolyl cephalosporin. | Pharmacotherapy 20021001 |
| Activity of cefditoren against respiratory pathogens. | The Journal of antimicrobial chemotherapy 20020701 |
| Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections. | Clinical therapeutics 20020701 |
| Cefditoren (Spectracef)--a new cephalosporin. | The Medical letter on drugs and therapeutics 20020121 |
| Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis. | Diagnostic microbiology and infectious disease 20020101 |
| In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren. | Diagnostic microbiology and infectious disease 20020101 |
| Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin. | Clinical therapeutics 20011201 |
| Oral prodrug enters cephalosporin market. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011101 |
| In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998. | The Journal of antimicrobial chemotherapy 20010801 |
| [Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year]. | The Japanese journal of antibiotics 20010501 |
| [Clinical isolates and treatment of acute otitis media]. | The Japanese journal of antibiotics 20010501 |
| [Therapy for children with acute pneumococcal otitis media in an outpatient clinic]. | The Japanese journal of antibiotics 20010501 |
| [High-dose cefditren therapy for children with acute otitis media that had Streptococcus pneumoniae and haemophilus influenzae isolated from the nasopharynx]. | The Japanese journal of antibiotics 20010501 |
| [Eradication of bacteria in upper pharynx of children treated with antibiotics]. | The Japanese journal of antibiotics 20010501 |
| [Mid term report of the CDTR clinical trial for PRSP and BLNAR infections]. | The Japanese journal of antibiotics 20010501 |
| [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections]. | The Japanese journal of antibiotics 20010501 |
| [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae]. | The Japanese journal of antibiotics 20010501 |
| [Isolation of bacteria and treatment of patients with pneumococcal and Haemophilus influenzae infections]. | The Japanese journal of antibiotics 20010501 |
| [Efficacy and safety of twice-daily administration of CTDR]. | The Japanese journal of antibiotics 20010501 |
| [Infant case of acute otitis media due to PISP not eradicated with double-dose of CDTR]. | The Japanese journal of antibiotics 20010501 |
| [Mode of transmission and natural course of pneumococcal infection]. | The Japanese journal of antibiotics 20010501 |
| [Study on Streptococcus pneumoniae isolated from infants in widely-separated primary care facilities in Japan]. | The Japanese journal of antibiotics 20010501 |
| Quality control parameters for cefditoren susceptibility tests. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010201 |
| Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001). | Diagnostic microbiology and infectious disease 20010101 |
| Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococci. | Chemotherapy 20010101 |
| Cefditoren in vitro activity and spectrum: a review of international studies using reference methods. | Diagnostic microbiology and infectious disease 20010101 |